Chad vs North Macedonia: Prevalence rate of hypertension in women aged 30-79
Chad
40.7
in 2019
North Macedonia
40.7
in 2019
Chad rank
71st
North Macedonia rank
71st
Prevalence rate of hypertension in women aged 30-79 over time
- Chad
- North Macedonia
How they compare
Chad currently reports 40.7 against 40.7 in North Macedonia, a difference of 0.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was North Macedonia ahead.
Chad ranks 71st and North Macedonia ranks 71st of 195 countries.
Across the 3 decades both report, Chad averaged higher in 1 and North Macedonia in 2.
Head to head by decade
| Decade | Chad | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 38.35 | 44.1 | 5.75 | North Macedonia |
| 2000s | 40.49 | 41.22 | 0.73 | North Macedonia |
| 2010s | 41.02 | 40.89 | 0.13 | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Chad or North Macedonia?
- Chad, at 40.7 against 40.7 in North Macedonia as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Chad and North Macedonia?
- 0, with Chad ahead.
- How many years of comparable data are there for Chad and North Macedonia?
- 30 years are reported by both, from 1990 to 2019.
- How do Chad and North Macedonia rank globally for prevalence rate of hypertension in women aged 30-79?
- Chad ranks 71st and North Macedonia ranks 71st of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.